Accounts Receivable are created when a customer has received a product but has not yet paid for that product. ChemoCentryx's accounts receivables for the quarter that ended in Jun. 2022 was $4.95 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
ChemoCentryx's Days Sales Outstanding for the quarter that ended in Jun. 2022 was 38.37.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. ChemoCentryx's Net-Net Working Capital per share for the quarter that ended in Jun. 2022 was $2.13.
ChemoCentryx Accounts Receivable Historical Data
The historical data trend for ChemoCentryx's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
ChemoCentryx Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
ChemoCentryx's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), ChemoCentryx's accounts receivable are only considered to be worth 75% of book value:
ChemoCentryx's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
ChemoCentryx Accounts Receivable Related Terms
Thank you for viewing the detailed overview of ChemoCentryx's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
ChemoCentryx Inc is a biopharmaceutical company involved in the discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The company's approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohn's disease, inflammatory bowel disease, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCXI has been successfully added to your 